(Total Views: 117)
Posted On: 03/16/2024 8:05:52 AM
Post# of 145184

$GSK News Article - Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer https://marketwirenews.com/news-releases/posi...08867.html


My Twitter: WhyteStocks